{"count": 58, "results": [{"_id": "34057517", "pmid": 34057517, "title": "Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril.", "journal": "Acta Chim Slov", "authors": ["Ibrahim LB", "Idowu PF", "Mose SOA", "Alabi MA", "Ajani EO"], "date": "2021-03-01T00:00:00Z", "meta_date_publication": "2021 Mar", "meta_volume": "68", "meta_issue": "1", "meta_pages": "127", "score": 50256.496, "text_hl": "Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@Diabetic@@@ @SPECIES_10116 @@@Rats@@@ Co-Administered with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@.", "citations": {"NLM": "Ibrahim LB, Idowu PF, Mose SOA, Alabi MA, Ajani EO. Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril. Acta Chim Slov. 2021 Mar;68(1):127. PMID: 34057517", "BibTeX": "@article{34057517, title={Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril.}, author={Ibrahim LB and Idowu PF and Mose SOA and Alabi MA and Ajani EO}, journal={Acta Chim Slov}, volume={68}, number={1}, pages={127}}"}}, {"_id": "9179532", "pmid": 9179532, "title": "Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.", "journal": "Drugs", "authors": ["Goa KL", "Haria M", "Wilde MI"], "date": "1997-06-01T00:00:00Z", "doi": "10.2165/00003495-199753060-00010", "meta_date_publication": "1997 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "1081-105", "score": 50073.367, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@. A review of its pharmacology and use in the management of the complications of @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetes mellitus@@@.", "citations": {"NLM": "Goa KL, Haria M, Wilde MI. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus. Drugs. 1997 Jun;53(6):1081-105. PMID: 9179532", "BibTeX": "@article{9179532, title={Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.}, author={Goa KL and Haria M and Wilde MI}, journal={Drugs}, volume={53}, number={6}, pages={1081-105}}"}}, {"_id": "21235127", "pmid": 21235127, "title": "Evaluation of some pharmaceutical formulations of lisinopril through dissolution testing.", "journal": "Rev Med Chir Soc Med Nat Iasi", "authors": ["Vieriu M", "Bibire N", "Apostu M", "Tocu C", "Dorneanu V", "Vlase C"], "date": "2010-07-01T00:00:00Z", "meta_date_publication": "2010 Jul-Sep", "meta_volume": "114", "meta_issue": "3", "meta_pages": "900-3", "score": 50067.066, "text_hl": "...AIM: @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ is a drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@congestive heart failure@@@, @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@heart attacks@@@ and also in preventing @DISEASE_Retinal_Diseases @DISEASE_MESH:D012164 @@@renal and retinal complications@@@ of @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Vieriu M, Bibire N, Apostu M, Tocu C, Dorneanu V, Vlase C. Evaluation of some pharmaceutical formulations of lisinopril through dissolution testing. Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):900-3. PMID: 21235127", "BibTeX": "@article{21235127, title={Evaluation of some pharmaceutical formulations of lisinopril through dissolution testing.}, author={Vieriu M and Bibire N and Apostu M and Tocu C and Dorneanu V and Vlase C}, journal={Rev Med Chir Soc Med Nat Iasi}, volume={114}, number={3}, pages={900-3}}"}}, {"_id": "11450501", "pmid": 11450501, "title": "The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats.", "journal": "Acta Diabetol", "authors": ["Koenen C", "Lang C", "Kempe HP", "Werle E", "Hasslacher C"], "date": "2000-01-01T00:00:00Z", "doi": "10.1007/s005920070003", "meta_date_publication": "2000", "meta_volume": "37", "meta_issue": "4", "meta_pages": "185-8", "score": 50066.695, "text_hl": "The influence of the ACE inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on the glomerular metabolism of proteolytic enzymes in @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Koenen C, Lang C, Kempe HP, Werle E, Hasslacher C. The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats. Acta Diabetol. 2000;37(4):185-8. PMID: 11450501", "BibTeX": "@article{11450501, title={The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats.}, author={Koenen C and Lang C and Kempe HP and Werle E and Hasslacher C}, journal={Acta Diabetol}, volume={37}, number={4}, pages={185-8}}"}}, {"_id": "19080636", "pmid": 19080636, "title": "[Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].", "journal": "Zhonghua Yi Xue Za Zhi", "authors": ["Han LP", "Yu DM", "Xie Y"], "date": "2008-09-16T00:00:00Z", "meta_date_publication": "2008 Sep 16", "meta_volume": "88", "meta_issue": "35", "meta_pages": "2513-5", "score": 50066.035, "text_hl": "The @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@ were randomly divided into 2 groups: @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ group treated with gastric perfusion of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ daily for 8 weeks, and @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetic@@@ control group. ", "citations": {"NLM": "Han LP, Yu DM, Xie Y. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats]. Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2513-5. PMID: 19080636", "BibTeX": "@article{19080636, title={[Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].}, author={Han LP and Yu DM and Xie Y}, journal={Zhonghua Yi Xue Za Zhi}, volume={88}, number={35}, pages={2513-5}}"}}, {"_id": "8410923", "pmid": 8410923, "title": "Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.", "journal": "J Hum Hypertens", "authors": ["O'Donnell MJ", "Rowe BR", "Lawson N", "Horton A", "Gyde OH", "Barnett AH"], "date": "1993-08-01T00:00:00Z", "meta_date_publication": "1993 Aug", "meta_volume": "7", "meta_issue": "4", "meta_pages": "327-32", "score": 50064.77, "text_hl": "Placebo-controlled trial of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in normotensive @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with incipient @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@.", "citations": {"NLM": "O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy. J Hum Hypertens. 1993 Aug;7(4):327-32. PMID: 8410923", "BibTeX": "@article{8410923, title={Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.}, author={O'Donnell MJ and Rowe BR and Lawson N and Horton A and Gyde OH and Barnett AH}, journal={J Hum Hypertens}, volume={7}, number={4}, pages={327-32}}"}}, {"_id": "2846685", "pmid": 2846685, "title": "Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.", "journal": "J Hypertens", "authors": ["Hartmann JF", "Szemplinski M", "Hayes NS", "Keegan ME", "Slater EE"], "date": "1988-08-01T00:00:00Z", "doi": "10.1097/00004872-198808000-00012", "meta_date_publication": "1988 Aug", "meta_volume": "6", "meta_issue": "8", "meta_pages": "677-83", "score": 50064.7, "text_hl": "Effects of the @GENE_ACE @GENE_24310 @@@angiotensin converting enzyme@@@ inhibitor, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, on normal and @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Hartmann JF, Szemplinski M, Hayes NS, Keegan ME, Slater EE. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens. 1988 Aug;6(8):677-83. PMID: 2846685", "BibTeX": "@article{2846685, title={Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.}, author={Hartmann JF and Szemplinski M and Hayes NS and Keegan ME and Slater EE}, journal={J Hypertens}, volume={6}, number={8}, pages={677-83}}"}}, {"_id": "29971804", "pmid": 29971804, "title": "An evidence-based systematic review of the off-label uses of lisinopril.", "journal": "Br J Clin Pharmacol", "authors": ["Sadat-Ebrahimi SR", "Parnianfard N", "Vahed N", "Babaei H", "Ghojazadeh M", "Tang S", "Azarpazhooh A"], "date": "2018-11-01T00:00:00Z", "doi": "10.1111/bcp.13705", "meta_date_publication": "2018 Nov", "meta_volume": "84", "meta_issue": "11", "meta_pages": "2502-2521", "score": 50063.926, "text_hl": "An evidence-based systematic review of the off-label uses of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@.", "citations": {"NLM": "Sadat-Ebrahimi SR, Parnianfard N, Vahed N, Babaei H, Ghojazadeh M, Tang S, Azarpazhooh A. An evidence-based systematic review of the off-label uses of lisinopril. Br J Clin Pharmacol. 2018 Nov;84(11):2502-2521. PMID: 29971804", "BibTeX": "@article{29971804, title={An evidence-based systematic review of the off-label uses of lisinopril.}, author={Sadat-Ebrahimi SR and Parnianfard N and Vahed N and Babaei H and Ghojazadeh M and Tang S and Azarpazhooh A}, journal={Br J Clin Pharmacol}, volume={84}, number={11}, pages={2502-2521}}"}}, {"_id": "9433426", "pmid": 9433426, "title": "Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.", "journal": "Lancet", "authors": ["Chaturvedi N", "Sjolie AK", "Stephenson JM", "Abrahamian H", "Keipes M", "Castellarin A", "Rogulja-Pepeonik Z", "Fuller JH"], "date": "1998-01-03T00:00:00Z", "doi": "10.1016/s0140-6736(97)06209-0", "meta_date_publication": "1998 Jan 3", "meta_volume": "351", "meta_issue": "9095", "meta_pages": "28-31", "score": 50060.82, "text_hl": "EURODIAB Controlled Trial of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in @CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@Insulin@@@-Dependent @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@Diabetes Mellitus@@@.", "citations": {"NLM": "Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998 Jan 3;351(9095):28-31. PMID: 9433426", "BibTeX": "@article{9433426, title={Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.}, author={Chaturvedi N and Sjolie AK and Stephenson JM and Abrahamian H and Keipes M and Castellarin A and Rogulja-Pepeonik Z and Fuller JH}, journal={Lancet}, volume={351}, number={9095}, pages={28-31}}"}}, {"_id": "14695037", "pmid": 14695037, "title": "Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.", "journal": "Pharmacotherapy", "authors": ["McConnell KJ", "Humphries TL", "Raebel MA", "Merenich JA", "Clinical Pharmacy Cardiac Risk Service Study Group"], "date": "2003-12-01T00:00:00Z", "doi": "10.1592/phco.23.15.1564.31963", "meta_date_publication": "2003 Dec", "meta_volume": "23", "meta_issue": "12", "meta_pages": "1564-72", "score": 50060.156, "text_hl": "Clinical pharmacy specialist implementation of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy in @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@ and @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetes mellitus@@@.", "citations": {"NLM": "McConnell KJ, Humphries TL, Raebel MA, Merenich JA, Clinical Pharmacy Cardiac Risk Service Study Group. Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus. Pharmacotherapy. 2003 Dec;23(12):1564-72. PMID: 14695037", "BibTeX": "@article{14695037, title={Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.}, author={McConnell KJ and Humphries TL and Raebel MA and Merenich JA and Clinical Pharmacy Cardiac Risk Service Study Group}, journal={Pharmacotherapy}, volume={23}, number={12}, pages={1564-72}}"}}]}